Endoscopic and histologic findings do not distinguish patients with inflammatory bowel disease who test positive for intestinal pathogens during an exacerbation of symptoms from those who test negative, researchers have found.
The retrospective single-center study looked for predictors that could help distinguish infections from flares. It focused on infectious agents other than Clostridium difficile infection (CDI). While DNA-based stool tests have enabled the rapid detection of multiple